Search company, investor...


Founded Year



Other Investors | Alive

About Thermosensorik

Thermosensorik GmbH was founded in October 1998 as spin-off of the university Erlangen-Nuremberg, chair of physics, to make infrared imaging systems and technologies available for the industrial and research market. Thermosensorik introduced infrared technology, so far only used for military purposes, as industrial measurement technique, especially for non-destructive testing.

Headquarters Location

6 Townsend Street Suite 271

San Francisco, California, 94103,

United States

Missing: Thermosensorik's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Thermosensorik's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Thermosensorik Patents

Thermosensorik has filed 2 patents.

patents chart

Application Date

Grant Date


Related Topics




Infrared imaging, Spectroscopy, Thermodynamics, Surveillance, Fluid dynamics


Application Date


Grant Date



Related Topics

Infrared imaging, Spectroscopy, Thermodynamics, Surveillance, Fluid dynamics



Thermosensorik Frequently Asked Questions (FAQ)

  • When was Thermosensorik founded?

    Thermosensorik was founded in 1998.

  • Where is Thermosensorik's headquarters?

    Thermosensorik's headquarters is located at 6 Townsend Street, San Francisco.

  • What is Thermosensorik's latest funding round?

    Thermosensorik's latest funding round is Other Investors.

  • Who are the investors of Thermosensorik?

    Investors of Thermosensorik include next47.

  • Who are Thermosensorik's competitors?

    Competitors of Thermosensorik include Xenics and 4 more.

Compare Thermosensorik to Competitors


Lynred develops infrared detectors for detection, recognition, or temperature measurement. It designs and manufactures infrared detectors for military, space, and commercial applications. It delivers its products to the aerospace, defense, security, surveillance, safety, and more sectors. It was founded in 1986 and is based in Palaiseau, France.

Infrared Cameras

Infrared Cameras develops and manufactures infrared camera technology. It offers handheld thermal cameras, infrared drone cameras, infrared equipment, thermal imaging systems, and more. It serves aerial, medical, industrial, electrical, and agricultural industries. The company was founded in 1995 and is based in Beaumont, Texas.


SiTec Consulting was established in 1996, on the basis of long experience in pharmaceutical R&D. The company developed a range of expertise working with pharmaceutical and biotech companies in the United States and in Europe.n SiTec Consulting offers pharmaceutical and biotechnology companies a variety of services in the areas of preformulation, drug development, drug delivery and formulation technologies evaluation, regulatory and cGLP/cGMP compliance. The company can actively collaborate with start-up pharmaceutical and drug delivery companies to provide scientific and strategic support in the establishment of the new company's activities. The company emphasize open communication, active involvement with the client and continuous feedback.n Networking is one of the company's assets, allowing us to cover the complex demands of the R&D process. The company have access to laboratories and equipment and resources, located at the Bioindustry Park Canavese, and at selected universities and research centers in Europe. This aims to give the possibility to conduct and manage experimental parts of projects at the company's clients' request.n The company value the importance of high quality training. In addition to the hands-on experience the company can provide to the company's clients, SiTec is an authorized representative of the Center for Professional Advancement, a worldwide private institution dedicated to the provision of continuing technical and scientific education at a professional level.


Adriacell s.r.l is a biotech company focused in oncology pharmaceuticals founded in Basovizza (Trieste) in March 2004 by Prof. Christian Kuehne, an Austrian citizen.nThe company is leveraging its efforts and scientific expertise to successfully solve important worldwide health problems; in particular, it has been striving to develop a new class of anti-tumour therapeutics and to create a series of powerful diagnostics for the early detection of cancer progression. The company is also developing new and highly powerful delivery solutions through small molecules as the basis for a new class of anti-infective drugs.nAdriaCell owns a patented system that can be used for the study of events subsequent to DNA double strand breaks, a very important issue for cancer research and diagnostics. Adriacell is currently evaluating a new class of therapeutics for cancer; its main lead compound is about to enter the pharmacokinetic and toxicology phases.nAdriacell Vision is to become a leader biotech drug development company concentrated in the development of solutions (treatment and diagnostics) for tumours characterized by low probability of survival for patients and of anti infective agents. Thanks to future developments in research and test activities Adriacell solutions will hopefully become useful in a wider range of pathologies.


ATNT is a biotech company which develops cross-disciplinary engineering methods, to find the most effective molecular targets for treatment of complex human disorders.

Dr. Alex Waldrop

Dr. Alex Waldrop has developed AcriGlow-301TM to detect the presence of hydrogen peroxide by chemilumniescence for medical and environmental purposes. The European patent has issued for this chemiluminescent technology developed with co-inventor Dr. Calvin Vary of MMCRI (Maine Medical Center Research Institute). Used as a detection system, the process can be adapted to detect a wide variety of substances. Developed with support of MMCRI, Jane Havey of Capricorn Products and the Maine Center for Innovation and Biotechnology (CIBT, the predecessor to MTI), Dr Waldrop hopes to license the technology to clients in the fields of bio-technology and environmental detection. Various companies in the United States, in Japan and in Spain have used the product on a trial basis. The U.S. patent is still pending. This technology has been applied to antibody-based diagnostics.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.